Litcius/Paper detail

Natural products that target macrophages in treating non-alcoholic steatohepatitis

Chunlin Li, Wenjun Zhou, Guang Ji, Li Zhang

2020World Journal of Gastroenterology10 citationsDOIOpen Access PDF

Abstract

Nonalcoholic steatohepatitis (NASH) is the progressive subtype of non-alcoholic fatty liver disease and potentiates risks for both hepatic and metabolic diseases. Although the pathophysiology of NASH is not completely understood, recent studies have revealed that macrophage activation is a major contributing factor for the disease progression. Macrophages integrate the immune response and metabolic process and have become promising targets for NASH therapy. Natural products are potential candidates for NASH treatment and have multifactorial underlying mechanisms. Macrophage involvement in the development of steatosis and inflammation in NASH has been widely investigated. In this review, we assess the evidence for natural products or their active ingredients in the modulation of macrophage activation, recruitment, and polarization, as well as the metabolic status of macrophages. Our work may highlight the possible natural products that target macrophages as potential treatment options for NASH.

Topics & Concepts

SteatohepatitisFatty liverMacrophage polarizationSteatosisMacrophageInflammationMedicineNonalcoholic steatohepatitisDiseaseImmunologyBioinformaticsNonalcoholic fatty liver diseaseBiologyInternal medicineBiochemistryIn vitroLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseasePancreatitis Pathology and Treatment